Attitudes and perceptions of naloxone dispensing among a sample of Massachusetts community pharmacy technicians

Rudd, 2016, Increases in drug and opioid-involved overdose deaths—United States, 2010–2015, MMWR Morb Mortal Wkly Rep, 65, 1445, 10.15585/mmwr.mm655051e1 O’Donnell, 2018, Notes from the field: overdose deaths with carfentanil and other fentanyl analogs detected–10 states, July 2016-June 2017, MMWR Morb Mortal Wkly Rep, 67, 767, 10.15585/mmwr.mm6727a4 Somerville, 2017, Characteristics of fentanyl overdose — Massachusetts, 2014–2016, MMWR Morb Mortal Wkly Rep, 66, 382, 10.15585/mmwr.mm6614a2 Gertner, 2018, Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid, Drug Alcohol Depend, 190, 37, 10.1016/j.drugalcdep.2018.05.014 Xu, 2018, State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies, Drug Alcohol Depend, 189, 37, 10.1016/j.drugalcdep.2018.04.020 Lambdin, 2018, Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States, Drug Alcohol Depend, 188, 370, 10.1016/j.drugalcdep.2018.04.004 Davis, 2017, State legal innovations to encourage naloxone dispensing, J Am Pharm Assoc (2003), 57, S180, 10.1016/j.japh.2016.11.007 Walley, 2013, Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis, BMJ, 346, f174, 10.1136/bmj.f174 Dowell, 2016, CDC guideline for prescribing opioids for chronic pain—United States, 2016, JAMA, 315, 1624, 10.1001/jama.2016.1464 Stone, 2018, Naloxone-prescribing practices: A missed opportunity, N C Med J, 79, 343 Binswanger, 2015, Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff, J Gen Intern Med, 30, 1837, 10.1007/s11606-015-3394-3 Green, 2017, Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states, J Am Pharm Assoc(2003), 57, S19 Evoy, 2018, Naloxone accessibility without a prescriber encounter under standing orders at community pharmacy chains in Texas, JAMA, 320, 1934, 10.1001/jama.2018.15892 Puzantian, 2018, Provision of naloxone without a prescription by California pharmacists 2 years after legislation implementation, JAMA, 320, 1933, 10.1001/jama.2018.12291 Zaller, 2012, Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention, J Health Care Poor Underserved, 23, 1310, 10.1353/hpu.2012.0094 Maine, 2013, Pharmacists and technicians can enhance patient care even more once national policies, practices, and priorities are aligned, Health Aff (Millwood), 32, 1956, 10.1377/hlthaff.2013.0529 Burson, 2016, Community pharmacies as sites of adult vaccination: a systematic review, Hum Vaccin Immunother, 12, 3146, 10.1080/21645515.2016.1215393 Powers, 2011, Pharmacy technicians and immunizations, J Pharm Technol, 27, 111 Hill, 2017, Development of a pharmacy technician–driven program to improve vaccination rates at an academic medical center, Hosp Pharm, 52, 617, 10.1177/0018578717722788 Bright, 2017, Pharmacy technician-administered vaccines in Idaho, Am J Health Syst Pharm, 74, 2033, 10.2146/ajhp170158 McKeirnan, 2018, Training pharmacy technicians to administer immunizations, J Am Pharm Assoc(2003), 58, 174 Freeman, 2017, Pharmacists’ role in opioid overdose: Kentucky pharmacists’ willingness to participate in naloxone dispensing, J Am Pharm Assoc(2003), 57, S28 Beletsky, 2007, Physicians’ knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities, J Urban Health, 84, 126 Raisch, 2005, Pharmacists’ and technicians’ perceptions and attitudes toward dispensing buprenorphine/naloxone to patients with opioid dependence, J Am Pharm Assoc, 45, 23, 10.1331/1544345052843200 Zaller, 2013, The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island, Subst Use Misuse, 48, 590, 10.3109/10826084.2013.793355 Morton, 2017, Pharmacy-based statewide naloxone distribution: a novel “top-down, bottom-up” approach, J Am Pharm Association, 57, S99, 10.1016/j.japh.2017.01.017 Green Behar, 2015, Brief overdose education is sufficient for naloxone distribution to opioid users, Drug Alcohol Depend, 148, 209, 10.1016/j.drugalcdep.2014.12.009 Frank Franko, 2017, Naloxone coverage remains a barrier to use, J Am Pharm Assoc (2003), 57, 740, 10.1016/j.japh.2017.05.017 Davis, 2017, Naloxone affordability measures needed, J Am Pharm Assoc (2003), 57, 740, 10.1016/j.japh.2017.06.001 Gupta, 2016, The rising price of naloxone —risks to efforts to stem overdose deaths, N Engl J Med, 375, 2213, 10.1056/NEJMp1609578 Meyerson, 2018, Predicting pharmacy syringe sales to people who inject drugs: policy, practice and perceptions, Int J Drug Policy, 56, 46, 10.1016/j.drugpo.2018.02.024 Chiarello, 2016, Nonprescription syringe sales: resistant pharmacists’ attitudes and practices, Drug Alcohol Depend, 166, 45, 10.1016/j.drugalcdep.2016.06.023 Albert, 2011, Project Lazarus: community-based overdose prevention in rural North Carolina, Pain Med, 12, S77, 10.1111/j.1526-4637.2011.01128.x